Background: Pluripotent stem cells (PSC) have tremendous potential in regenerative medicine, cell therapy, and drug/toxicant screening, and can increase our understanding of the pathogenesis and treatment of disease. The stem cell industry has accelerated annual growth projections of 20% by 2020. Overall, there is growing demand for culture media that can support rapid growth, survival, and sustain pluripotency of stem cells. Brief Description: UCR researchers have developed a novel, non-toxic biological compound that can be added to any culture medium to prevent unwanted differentiation. Compared to the standard commercial media currently used in PSC laboratories, this compound produces major improvements in cell quality, cell growth and maintenance of pluripotency during repeated passaging. Additionally, regulatory groups categorize stem cell therapy as an orphan drug, thereby allowing accelerated approval.